Ignite Creation Date:
2025-12-24 @ 5:09 PM
Ignite Modification Date:
2026-01-31 @ 11:42 PM
Study NCT ID:
NCT00657150
Status:
COMPLETED
Last Update Posted:
2014-07-02
First Post:
2008-03-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Dabigatran Etexilate Compared With Enoxaparin in Prevention of Venous Thromboembolism (VTE) Following Total Hip Arthroplasty
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-03
Start Date Type:
None
Primary Completion Date:
2009-09
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2008-03-27
First Submit QC Date:
None
Study First Post Date:
2008-04-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-11-18
Results First Submit QC Date:
None
Results First Post Date:
2010-12-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-06-23
Last Update Post Date:
2014-07-02
Last Update Post Date Type:
ESTIMATED